Pharmaceuticals, Biotechnology and Life Sciences
Data from 5,518 Patients were Critical to Achieving the Broader IndicationCLEVELAND, Ohio, Oct. 19, 2021 (GLOBE NEWSWIRE) — SPR Therapeutics®…
Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to…
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third…
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company…
— TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company’s precision oncology pipeline — — Calithera will initiate Phase…
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery,…
— Potential $1 Billion Addressable Market Opportunity in the United StatesBOSTON, Oct. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc.…
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patientsStatistically significant difference in clinical cure…
FOSTER CITY, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor Naïve Patients with Advanced Cancers Poster for…